rxstat › Classes › Psychostimulants And Nootropics

Psychostimulants And Nootropics: shortage status in Canada

6 of the 6 psychostimulants and nootropics rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Atomoxetine (Strattera) Partial shortage 13 of 63 reported products affected · est. return Dec 31, 2026 Dextroamphetamine (Dexedrine Spansule Src) Partial shortage 2 of 6 reported products affected Lisdexamfetamine (Vyvanse) Partial shortage 3 of 18 reported products affected · est. return Aug 7, 2026 Methylphenidate (Biphentin) Partial shortage 5 of 59 reported products affected · est. return Nov 15, 2026 Mixed Salts Amphetamine (Adderall) Partial shortage 3 of 25 reported products affected · est. return Aug 14, 2026 Modafinil (Alertec) Partial shortage 1 of 6 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.